Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Aug 29, 2022

50715_rns_2022-08-29_33cf6c94-d2ea-40f1-b535-1ee7e106e63c.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

29 August 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Descriptionof relevantsecurities Nature of dealings Purchase/ Sale Totalnumber ofsharesinvolved Total amountpaid / received Highest (H)prices paid/ received Lowest (L)prices paid/ received
China InternationalCapital CorporationLimited 26 August2022 Ordinaryshares Hedging as a result of thecreation of new index-trackingETFs where the relevantsecurities represent less than1% of the class in issue andless than 20% of the value ofthe securities in the basket orindex Purchase 500 $24,679.0000 $50.1900 $49.1500

Public Disclosure Form

==> picture [71 x 43] intentionally omitted <==

Ordinary Disposal of the underlying Sale 2,100 $104,767.0000 $49.9609 $49.8100
shares shares received from the
redemption of pre-existing
index-tracking ETFs as a result
of unsolicited client requests

End

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.

The shares reported refer to A shares of Yankuang Energy Group Company Limited (600188.SH), and price per unit is in RMB.